156 related articles for article (PubMed ID: 24193887)
1. The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry.
McCombs J; Matsuda T; Tonnu-Mihara I; Saab S; Hines P; L'italien G; Juday T; Yuan Y
JAMA Intern Med; 2014 Feb; 174(2):204-12. PubMed ID: 24193887
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.
Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
Hepatology; 2017 Sep; 66(3):784-793. PubMed ID: 28370058
[TBL] [Abstract][Full Text] [Related]
3. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
[TBL] [Abstract][Full Text] [Related]
4. A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.
Backus LI; Boothroyd DB; Phillips BR; Belperio P; Halloran J; Mole LA
Clin Gastroenterol Hepatol; 2011 Jun; 9(6):509-516.e1. PubMed ID: 21397729
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
[TBL] [Abstract][Full Text] [Related]
7. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
8. Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
Belperio PS; Hwang EW; Thomas IC; Mole LA; Cheung RC; Backus LI
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1021-7. PubMed ID: 23524130
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
Nainan OV; Alter MJ; Kruszon-Moran D; Gao FX; Xia G; McQuillan G; Margolis HS
Gastroenterology; 2006 Aug; 131(2):478-84. PubMed ID: 16890602
[TBL] [Abstract][Full Text] [Related]
10. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
11. Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients.
Crawford DH; Dore GJ; Sievert W; Cheng WS; Weltman M; McCaughan G; Rawlinson W; Marks PS; Yoshihara M; Rizkalla B; Roberts SK;
Antivir Ther; 2012; 17(5):849-54. PubMed ID: 22513456
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus load and survival among injection drug users in the United States.
Hisada M; Chatterjee N; Kalaylioglu Z; Battjes RJ; Goedert JJ
Hepatology; 2005 Dec; 42(6):1446-52. PubMed ID: 16317675
[TBL] [Abstract][Full Text] [Related]
13. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
14. Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus.
Shindoh J; Hasegawa K; Matsuyama Y; Inoue Y; Ishizawa T; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
J Clin Oncol; 2013 Feb; 31(6):766-73. PubMed ID: 23129744
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey].
Aktaş E; Ogedey ED; Külah C; Beğendik Cömert F
Mikrobiyol Bul; 2010 Oct; 44(4):647-50. PubMed ID: 21063977
[TBL] [Abstract][Full Text] [Related]
16. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
17. Quality of care in patients with chronic hepatitis C virus infection: a cohort study.
Kanwal F; Schnitzler MS; Bacon BR; Hoang T; Buchanan PM; Asch SM
Ann Intern Med; 2010 Aug; 153(4):231-9. PubMed ID: 20713791
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
19. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.
Kanwal F; Kramer JR; Ilyas J; Duan Z; El-Serag HB
Hepatology; 2014 Jul; 60(1):98-105. PubMed ID: 24615981
[TBL] [Abstract][Full Text] [Related]
20. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
